Combined Compendium of Food Additive Specifications
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Notice of Modification to the List of Permitted Food Enzymesto Enable
Notice of Modification to the List of Permitted Food Enzymes to Enable the Use of Lysophospholipase from Trichoderma reesei RF7206 in the Production of Sugars and Dextrins from Starch Notice of Modification – Lists of Permitted Food Additives Reference Number: NOM/ADM-0172 August 10, 2021 Summary Food additives are regulated in Canada under Marketing Authorizations (MAs) issued by the Minister of Health and the Food and Drug Regulations (Regulations). Approved food additives and their permitted conditions of use are set out in the Lists of Permitted Food Additives that are incorporated by reference in the MAs and published on the Canada.ca website. A petitioner can request that Health Canada approve a new additive or a new condition of use for an already approved food additive by filing a food additive submission with the Department's Food Directorate. Health Canada uses this premarket approval process to determine whether the scientific data support the safety of food additives when used under specified conditions in foods sold in Canada. Health Canada’s Food Directorate received a food additive submission seeking approval for the use of lysophospholipase from Trichoderma reesei RF7206 in starch used in the production of dextrins, dextrose, fructose syrups and solids, glucose (glucose syrup), glucose solids (dried glucose syrup), or maltose. The food enzyme is intended to be used at a level consistent with Good Manufacturing Practice1. Its purpose of use is to improve the efficiency of the starch processing. Lysophospholipase is a type of phospholipase. Phospholipase from other microbial sources is already permitted for use in Canada as a food enzyme in certain foods, but not in the production of sugars and dextrins from starch. -
A Thesis Entitled Phor, Phop and Mshc
A Thesis entitled PhoR, PhoP and MshC: Three essential proteins of Mycobacterium tuberculosis by Erica Loney Submitted to the Graduate Faculty as partial fulfillment of the requirements for the Master of Science Degree in Chemistry __________________________________ Dr. Donald R. Ronning, Committee Chair __________________________________ Dr. John J. Bellizzi, Committee Member __________________________________ Dr. Ronald Viola, Committee Member __________________________________ Dr. Patricia R. Komuniecki, Dean College of Graduate Studies The University of Toledo May 2014 Copyright 2014, Erica Loney This document is copyrighted material. Under copyright law, no parts of this document may be produced without the expressed permission of the author. An Abstract of PhoR, PhoP and MshC: Three essential proteins of Mycobacterium tuberculosis by Erica Loney Submitted to the Graduate Faculty as partial fulfillment of the requirements for the Master of Science Degree in Chemistry The University of Toledo May 2014 The tuberculosis (TB) pandemic is responsible for 1.6 million deaths annually, most of which occur in developing nations. TB is treatable, though patient non- compliance, co-infection with HIV, and the long, 6-9 month treatment regimen have resulted in the emergence of drug-resistant TB. For these reasons, the development of novel anti-tuberculin drugs is essential. Three proteins – PhoR, PhoP, and MshC – of Mycobacterium tuberculosis (M.tb), the causative agent of TB, are the focus of this thesis. The PhoPR two-component system is a phosphorelay system responsible for the virulence of M.tb. The histidine kinase PhoR responds to a yet-unknown environmental stimulus and autophosphorylates a conserved histidine. The phosphate is transferred to an aspartate of the response regulator PhoP, which then forms a head-to-head homodimer and initiates the transcription of 114 virulence genes. -
Nicolet Condensed Phase Academic Sampler
Nicolet Condensed Phase Academic Sampler Library Listing – 1,000 spectra This high resolution format library is suited to the needs of academic institutions and small QC labs. Chosen by chemistry professors from many disciplines, it includes spectra of chemicals used in a wide range of common laboratory experiments. The Nicolet Condensed Phase Academic Sampler includes 1,000 spectra of common chemicals representing the major functional groups and combinations of functional groups which are most likely to be observed in academic chemistry laboratories. These chemicals are also important building blocks commonly found in industrial applications. Thermo Nicolet Condensed Phase Academic Sampler Index Compound Name Index Compound Name 353 (+)-2-Phenyl-1-propanol, 97% 164 1,2,4,5-Tetramethylbenzene, 98% 768 (+)-4-Cholesten-3-one 161 1,2,4-Trimethylbenzene, 99+% 290 (+)-a-Lactose 254 1,2-Butanediol, 98% 262 (+)-b-Citronellol, 95% 499 1,2-Diaminopropane, 99% 344 (+/-)-1-Phenyl-1-propanol, 99% 128 1,2-Dibromoethylene, 98%, (Z) + (E) 101 (+/-)-2-Bromopentane, 97% 106 1,2-Dichloroethane, 99+% 228 (+/-)-2-Butanol, 99% 110 1,2-Dichloropropane, 99% 233 (+/-)-2-Heptanol, 96% 258 1,2-Pentanediol, tech., 95% 402 (+/-)-Camphor, 97% 550 1,2-Phenylenediamine, 98% 553 (+/-)-Epinephrine, 99% 77 1,3,5,7-Cyclooctatetraene, 98% 280 (+/-)-Isoborneol, 85% 45 1,3,5-Hexatriene 706 (+/-)-Warfarin, 98% 74 1,3-Cycloheptadiene, 97% 648 (+/-)-sec-Butyl acetate, 99% 72 1,3-Cyclohexadiene, 96% 490 (+/-)-sec-Butylamine, 99% 388 1,3-Cyclohexanedione, 97% 279 (-)-Borneol, -
Synthetic and Mechanistic Investigations in Organophosphorus Chemistry Towards an Alternative Mitsunobu Protocol
Synthetic and Mechanistic Investigations of Some Novel Organophosphorus Reagents Author Fairfull-Smith, Kathryn Elizabeth Published 2004 Thesis Type Thesis (PhD Doctorate) School School of Science DOI https://doi.org/10.25904/1912/3875 Copyright Statement The author owns the copyright in this thesis, unless stated otherwise. Downloaded from http://hdl.handle.net/10072/367534 Griffith Research Online https://research-repository.griffith.edu.au SYNTHETIC AND MECHANISTIC INVESTIGATIONS OF SOME NOVEL ORGANOPHOSPHORUS REAGENTS KATHRYN ELIZABETH FAIRFULL-SMITH (née ELSON) BSc (Hons) School of Science Faculty of Science Griffith University Submitted in fulfilment of the requirements of the Degree of Doctor of Philosophy May 2004 i Statement of Originality This work has not previously been submitted for a degree or diploma in any University. To the best of my knowledge and belief, this thesis contains no material previously published or written by another person except where due reference is made in the thesis itself. Kathryn Fairfull-Smith (née Elson) BSc (Hons) ii Preface Unless otherwise stated, the results in this thesis are those of the author. Parts of this work have appeared elsewhere. Refereed journal publications are submitted with the dissertation and are presented in Appendix Two. Refereed Journal Publications ‘The Hendrickson reagent and the Mitsunobu reaction : a mechanistic study’ Kathryn E. Elson, Ian D. Jenkins and Wendy A. Loughlin, Org. Biomol. Chem., 2003, 1, 2958-2965. ‘Cyclic analogues of the Hendrickson ‘POP’ reagent’ Kathryn E. Elson, Ian D. Jenkins and Wendy A. Loughlin, Aust. J. Chem., 2004, 57, 371-376. ‘Polymer-supported triphenylphosphine ditriflate : a novel dehydrating reagent’ Kathryn E. Elson, Ian D. -
Alkanoyl Lactyl Lactate Salts As Used in Cosmetics
Safety Assessment of Alkanoyl Lactyl Lactate Salts as Used in Cosmetics Status: Final Report Release Date: July 17, 2019 Panel Date: June 6-7, 2019 The 2019 Cosmetic Ingredient Review Expert Panel members are: Chair, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V. Belsito, M.D.; Ronald A. Hill, Ph.D.; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; James G. Marks, Jr., M.D.; Ronald C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and Paul W. Snyder, D.V.M., Ph.D. The CIR Executive Director is Bart Heldreth, Ph.D. This report was prepared by Wilbur Johnson, Jr., M.S., Senior Scientific Analyst. © Cosmetic Ingredient Review 1620 L STREET, NW, SUITE 1200 ◊ WASHINGTON, DC 20036-4702 ◊ PH 202.331.0651 ◊ FAX 202.331.0088 ◊ [email protected] ABSTRACT: The Cosmetic Ingredient Review (CIR) Expert Panel (Panel) reviewed the safety of 10 alkanoyl lactyl lactate salts. These ingredients have the surfactant function in cosmetics in common. The Panel reviewed data relevant to the safety of these ingredients, and concluded that these 10 ingredients are safe in cosmetics in the present practices of use and concentration described in the safety assessment when formulated to be non-irritating and non-sensitizing, which may be based on a quantitative risk assessment (QRA) or other accepted methodologies. INTRODUCTION The safety of the following 10 alkanoyl lactyl lactate salts as used in cosmetics is reviewed in this Cosmetic Ingredient Review (CIR) safety assessment. Calcium Stearoyl Lactylate Sodium Cupheoyl Lactylate Sodium Behenoyl Lactylate Sodium Isostearoyl -
Thesis Has Been Carried out in the School of Pharmacy and Pharmacology and in the School of Biology and Biochemistry, Under the Supervision of Dr Michael D
University of Bath PHD Inhibitors of DNA repair processes as potentiating drugs in cancer radiotherapy and chemotherapy Watson, Corrine Yvonne Award date: 1997 Awarding institution: University of Bath Link to publication Alternative formats If you require this document in an alternative format, please contact: [email protected] General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal ? Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Download date: 10. Oct. 2021 Inhibitors of DNA Repair Processes as Potentiating Drugs in Cancer Radiotherapy and Chemotherapy submitted by Corrine Yvonne Watson for the degree of PhD of the University of Bath 1997 The research work in this thesis has been carried out in the School of Pharmacy and Pharmacology and in the School of Biology and Biochemistry, under the supervision of Dr Michael D. Threadgill and Dr William J. D. Whish. COPYRIGHT Attention is drawn to the fact that copyright of this thesis rests with its author. -
Organic Chemistry/Fourth Edition: E-Text
CHAPTER 17 ALDEHYDES AND KETONES: NUCLEOPHILIC ADDITION TO THE CARBONYL GROUP O X ldehydes and ketones contain an acyl group RC± bonded either to hydrogen or Ato another carbon. O O O X X X HCH RCH RCRЈ Formaldehyde Aldehyde Ketone Although the present chapter includes the usual collection of topics designed to acquaint us with a particular class of compounds, its central theme is a fundamental reaction type, nucleophilic addition to carbonyl groups. The principles of nucleophilic addition to alde- hydes and ketones developed here will be seen to have broad applicability in later chap- ters when transformations of various derivatives of carboxylic acids are discussed. 17.1 NOMENCLATURE O X The longest continuous chain that contains the ±CH group provides the base name for aldehydes. The -e ending of the corresponding alkane name is replaced by -al, and sub- stituents are specified in the usual way. It is not necessary to specify the location of O X the ±CH group in the name, since the chain must be numbered by starting with this group as C-1. The suffix -dial is added to the appropriate alkane name when the com- pound contains two aldehyde functions.* * The -e ending of an alkane name is dropped before a suffix beginning with a vowel (-al) and retained be- fore one beginning with a consonant (-dial). 654 Back Forward Main Menu TOC Study Guide TOC Student OLC MHHE Website 17.1 Nomenclature 655 CH3 O O O O CH3CCH2CH2CH CH2 CHCH2CH2CH2CH HCCHCH CH3 4,4-Dimethylpentanal 5-Hexenal 2-Phenylpropanedial When a formyl group (±CHœO) is attached to a ring, the ring name is followed by the suffix -carbaldehyde. -
ELECTRONICS AUTHENTICITY TESTING USING COMPREHENSIVE TWO-DIMENSIONAL GAS CHROMATOGRAPHY by Joseph C
ELECTRONICS AUTHENTICITY TESTING USING COMPREHENSIVE TWO-DIMENSIONAL GAS CHROMATOGRAPHY by Joseph C. Cacciatore A Thesis Submitted to the Faculty of Purdue University In Partial Fulfillment of the Requirements for the degree of Master of Science School of Engineering Technology West Lafayette, Indiana December 2019 2 THE PURDUE UNIVERSITY GRADUATE SCHOOL STATEMENT OF COMMITTEE APPROVAL Dr. J. Eric Dietz, Chair Department of Computer and Information Technology Dr. Gozdem Kilaz, Chair School of Engineering Technology Dr. Ken Burbank School of Engineering Technology Approved by: Dr. Duane Dunlap Head of the Graduate Program 2 TABLE OF CONTENTS LIST OF TABLES .......................................................................................................................... 5 LIST OF FIGURES ........................................................................................................................ 6 LIST OF ABBREVIATIONS ......................................................................................................... 7 DEFINITIONS ................................................................................................................................ 8 ABSTRACT .................................................................................................................................... 9 INTRODUCTION .............................................................................................. 10 1.1 Introduction to the Problem ............................................................................................. -
To FCC 11, First Supplement the Following Index Is for Convenience and Informational Use Only and Shall Not Be Used for Interpretive Purposes
Index to FCC 11, First Supplement The following Index is for convenience and informational use only and shall not be used for interpretive purposes. In addition to effective articles, this Index may also include items recently omitted from the FCC in the indicated Book or Supplement. The monographs and general tests and assay listed in this Index may reference other general test and assay specifications. The articles listed in this Index are not intended to be autonomous standards and should only be interpreted in the context of the entire FCC publication. For the most current version of the FCC please see the FCC Online. First Supplement, FCC 11 Index / Allyl Beta-phenylacrylate / I-1 Index Titles of monographs are shown in the boldface type. A 2-Acetyl Thiazole, 18 Alcohol C-8, 863 Acetyl Valeryl, 562 Alcohol C-9, 854 Abbreviations, 6, 1726 Acetyl Value, 1400 Alcohol C-10, 362 Absolute Alcohol (Reagent), 5, 1725 Achilleic Acid, 24 Alcohol C-11, 1231 Acacia, 556 Acid (Reagent), 5, 1725 Alcohol C-12, 681 ªAccuracyº, Defined, 1538 Acid-Hydrolyzed Milk Protein, 22 Alcohol C-16, 569 Acesulfame K, 9 Acid-Hydrolyzed Proteins, 22 Alcohol Content of Ethyl Oxyhydrate Acesulfame Potassium, 9 Acid Calcium Phosphate, 219 Flavor Chemicals (Other than Acetal, 10 Acid Hydrolysates of Proteins, 22 Essential Oils), 1437 Acetaldehyde, 10 Acidic Sodium Aluminum Phosphate, Alcohol, Diluted, 1524 Acetaldehyde Diethyl Acetal, 10 1065 Alcoholic Potassium Hydroxide TS, Acetaldehyde Test Paper, 1535 Acidified Sodium Chlorite 1524 Acetals (Essential Oils and Flavors), -
Dietary Supplements Compendium Volume 1
2015 Dietary Supplements Compendium DSC Volume 1 General Notices and Requirements USP–NF General Chapters USP–NF Dietary Supplement Monographs USP–NF Excipient Monographs FCC General Provisions FCC Monographs FCC Identity Standards FCC Appendices Reagents, Indicators, and Solutions Reference Tables DSC217M_DSCVol1_Title_2015-01_V3.indd 1 2/2/15 12:18 PM 2 Notice and Warning Concerning U.S. Patent or Trademark Rights The inclusion in the USP Dietary Supplements Compendium of a monograph on any dietary supplement in respect to which patent or trademark rights may exist shall not be deemed, and is not intended as, a grant of, or authority to exercise, any right or privilege protected by such patent or trademark. All such rights and privileges are vested in the patent or trademark owner, and no other person may exercise the same without express permission, authority, or license secured from such patent or trademark owner. Concerning Use of the USP Dietary Supplements Compendium Attention is called to the fact that USP Dietary Supplements Compendium text is fully copyrighted. Authors and others wishing to use portions of the text should request permission to do so from the Legal Department of the United States Pharmacopeial Convention. Copyright © 2015 The United States Pharmacopeial Convention ISBN: 978-1-936424-41-2 12601 Twinbrook Parkway, Rockville, MD 20852 All rights reserved. DSC Contents iii Contents USP Dietary Supplements Compendium Volume 1 Volume 2 Members . v. Preface . v Mission and Preface . 1 Dietary Supplements Admission Evaluations . 1. General Notices and Requirements . 9 USP Dietary Supplement Verification Program . .205 USP–NF General Chapters . 25 Dietary Supplements Regulatory USP–NF Dietary Supplement Monographs . -
Fcc-9-Second-Supplement-Index.Pdf
Index to FCC 9, Second Supplement The following Index is for convenience and informational use only and shall not be used for interpretive purposes. In addition to effective articles, this Index may also include items recently omitted from the FCC in the indicated Book or Supplement. The monographs and general tests and assay listed in this Index may reference other general test and assay specifications. The articles listed in this Index are not intended to be autonomous standards and should only be interpreted in the context of the entire FCC publication. For the most current version of the FCC please see the FCC Online. Second Supplement, FCC 9 Index / Allura Red AC / I-1 Index Titles of monographs are shown in the boldface type. A 2-Acetylpyrrole, 21 Alcohol, Absolute, 1486 2-Acetyl Thiazole, 18 Alcohol, Aldehyde-Free, 1487 Abbreviations, 7, 1813, 1899 Acetyl Valeryl, 563 Alcohol C-6, 579 Absolute Alcohol (Reagent), 6, 1812, Acetyl Value, 1425 Alcohol C-8, 867 1898 Achilleic Acid, 25 Alcohol C-9, 856 Acacia, 557 Acid (Reagent), 6, 1812, 1898 Alcohol C-10, 355 ªAccuracyº, Defined, 1503 Acid-Hydrolyzed Milk Protein, 22 Alcohol C-11, 1247 Acesulfame K, 9, 1901 Acid-Hydrolyzed Proteins, 22 Alcohol C-12, 675 Acesulfame Potassium, 9, 1901 Acid Calcium Phosphate, 213 Alcohol C-16, 1924 Acetal, 10 Acid Hydrolysates of Proteins, 22 Alcohol Content of Ethyl Oxyhydrate Acetaldehyde, 11 Acidic Sodium Aluminum Phosphate, Flavor Chemicals (Other than Acetaldehyde Diethyl Acetal, 10 1071 Essential Oils), 1462 Acetaldehyde Test Paper, 1498 Acidified -
The International Pharmacopoeia
The International Pharmacopoeia THIRD EDITION Pharmacopoea internationalis Editio tertia Volume 4 Tests, methods, and general requirements Quality specifications for pharmaceutical substances, excipients, and dosage forms World Health Organization Geneva 1994 WHO Library Cataloguing in Publication Data The International Pharmacopoeia.- 3rd ed. Contents: v. 4. Tests, methods, and general requirements 1. Drugs -analysis 2. Drugs -standards ISBN 92 4 154462 7 (NLM Classification: QV 25) The World Health Organization welcomes requests for permission to reproduce or translate its publica- tions, in part or in full. Applications and enquiries should be addressed to the Of£ice of Publications, World Health Organization, Geneva, Switzerland, which will be glad to provide the latest information on any changes made to the text, plans for new editions, and reprints and translations already available. O World Health Organization, 1994 Publications of the World Health Organization enjoy copyright protection in accordance with the provi- sions of Protocol 2 of the Universal Copyright Convention. All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distin- guished by initial capital letters.